文献速递临床试验与 GCP

手法治疗联合运动对轻度慢性阻塞性肺疾病的影响:随机对照试验研究方案

The effect of combining manual therapy with exercise for mild chronic obstructive pulmonary disease: study protocol for a randomised controlled trial.
PubMed 文献 · Trials · 2017-06-17

本研究为随机对照试验,纳入202例稳定期轻度COPD患者,随机分为标准化运动组和手法治疗(含脊柱手法治疗)联合标准化运动组。运动共36次、持续18周,手法治疗联合运动共15次、持续6周。主要结局为肺功能(FEV1和FVC),次要结局包括6分钟步行试验、生活质量、焦虑抑郁、急性加重频率、胸壁扩张和全身炎症生物标志物,由盲法评估者在48周内进行7次测量。

要点

  • 研究纳入202例稳定期轻度COPD患者,随机分为运动组和手法治疗联合运动组。
  • 运动共36次、持续18周;手法治疗联合运动共15次、持续6周。
  • 主要结局为FEV1和FVC,次要结局包括6MWT、SGRQ、HADS、急性加重频率、胸壁扩张和炎症生物标志物。

核心结论

  • 本随机对照试验旨在研究手法治疗联合运动相比单纯运动是否能为轻度COPD患者带来额外获益。

研究设计与样本

  • 随机对照试验,纳入202例稳定期轻度COPD患者,分为两组并在基线时匹配。
  • 第一组接受标准化运动方案;第二组接受包含脊柱手法治疗的手法治疗联合相同的标准化运动方案。
  • 运动共36次、持续18周;手法治疗联合运动共15次、持续6周。
  • 结局由盲法评估者在48周内进行7次测量,不良事件数据在每次干预开始时收集。

关键数值与推荐

  • 主要结局指标为肺功能(第1秒用力呼气容积FEV1和用力肺活量FVC)。
  • 次要结局指标包括6分钟步行试验(6MWT)、圣乔治呼吸问卷(SGRQ)、医院焦虑抑郁量表(HADS)、急性加重频率、胸壁扩张测量(卷尺测量)和全身炎症生物标志物水平。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a major cause of disability and hospital admission. Current management strategies have not been successful in altering the loss of lung function typically seen as the disease progresses. A recent systematic review into the use of spinal manipulative therapy (SMT) in the management of COPD concluded that there was low level evidence to support the view that a combination of SMT and exercise had the potential to improve lung function more than exercise alone in people with moderate to severe COPD. The aim of this study is to investigate whether the combination of exercise and manual therapy (MT) that includes SMT produces sustainable improvements in lung function and exercise capacity in people with mild COPD. METHODS/DESIGN: The study is a randomised controlled trial of 202 people with stable mild COPD. The cohort will be divided into two equal groups matched at baseline. The first group will receive a standardised exercise program. The second group will receive MT that includes SMT plus the same standardised exercise program. Exercise will be administered a total of 36 times over an 18-week period, while MT will be administered in conjunction with exercise a total of 15 times over a 6-week period. The primary outcome measure is lung function (forced expiratory volume in the 1st second: FEV1 and forced vital capacity: FVC). The secondary outcome measures are the 6-minute walking test (6MWT), quality of life questionnaire (St George's Respiratory Questionnaire: SGRQ), anxiety and depression levels (Hospital Anxiety and Depression Scale: HADS), frequency of exacerbations, chest wall expansion measurements (tape measurements) and systemic inflammatory biomarker levels. Outcome measurements will be taken by blinded assessors on seven occasions over a 48-week period. Adverse event data will also be gathered at the beginning of each intervention session. DISCUSSION: This randomised controlled trial is designed to investigate whether the combination of MT and exercise delivers any additional benefits to people with mild COPD compared to exercise alone. The study is designed in response to recommendations from a recent systematic review calling for more research into the effect of MT in the management of COPD. TRIAL REGISTRATION: ANZCTRN, 12614000766617 . Registered on 18 July 2014.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Engel RM, Wearing J, Gonski P, et al. The effect of combining manual therapy with exercise for mild chronic obstructive pulmonary disease: study protocol for a randomised controlled trial. Trials. 2017. PMID: 28623944. doi:10.1186/s13063-017-2027-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。